Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics
journal contribution
posted on 2023-10-24, 05:04authored byNajoua Lalaoui, Kay Hänggi, Gabriela Brumatti, Diep Chau, Nhu-Y N Nguyen, Lazaros Vasilikos, Lisanne M Spilgies, Denise A Heckmann, Chunyan Ma, Margherita Ghisi, Jessica M Salmon, Geoffrey M Matthews, Elisha de Valle, Donia M Moujalled, Manoj B Menon, Sukhdeep Kaur Spall, Stefan P Glaser, Jennifer Richmond, Richard B Lock, Stephen M Condon, Raffi Gugasyan, Matthias Gaestel, Mark GuthridgeMark Guthridge, Ricky W Johnstone, Lenka Munoz, Andrew Wei, Paul G Ekert, David L Vaux, W Wei-Lynn Wong, John Silke
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics